FDA seeks regulatory flexibility

被引：0

|

作者：

Wechsler, Jill ^{[1
]}

机构：

[1] 7715 Rooton Ave., Chevy Chase, MD 20815, United States

来源：

Pharmaceutical Technology | 2008年 / 32卷 / 03期

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：36 / 44

相关论文

共 50 条

[31] FDA Seeks to Revive Quality Metrics Initiative
Wechsler, Jill
BIOPHARM INTERNATIONAL, 2018, 31 (08) : 8 - 9
[32] Pharmaceuticals - DuPont seeks FDA protection of Coumadin
不详
EUROPEAN CHEMICAL NEWS, 1997, 68 (1792): : 4 - 4
[33] FDA seeks to phase out trans fat
Nachay, Karen
FOOD TECHNOLOGY, 2013, 67 (12) : 12 - 12
[34] FDA SEEKS TO INFORM PUBLIC ON RADIATION HAZARDS
不详
HEALTH SERVICES REPORT, 1972, 87 (05): : 437 - &
[35] FDA seeks to stop Web sales of laetrile
不详
CHEMICAL & ENGINEERING NEWS, 2000, 78 (37) : 17 - 17
[36] FDA SEEKS SUGGESTIONS FOR IMPROVING MEDICATION INFORMATION
Aschenbrenner, Diane S.
AMERICAN JOURNAL OF NURSING, 2009, 109 (04) : 31 - 31
[37] FDA seeks improvements in infusion pump safety
Traynor, Kate
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (13) : 1048 - 1049
[38] US FDA seeks linked ADR data
Reactions Weekly, 1998, 711 (1) : 3 - 3
[39] FDA seeks to modify regulation of medical devices
Roehr, Bob
BRITISH MEDICAL JOURNAL, 2010, 341
[40] Amylyx’s ALS therapy secures FDA approval, as regulatory flexibility trumps underwhelming data
Asher Mullard
Nature Reviews Drug Discovery, 2022, 21 : 786 - 786

← 1 2 3 4 5 →